Amicus Therapeutics CEO John Crowley episode artwork

EPISODE · Jun 4, 2021 · 30 MIN

Amicus Therapeutics CEO John Crowley

from Talks at GS · host Goldman Sachs

In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Jun 4, 2021

Embed this episode

NOW PLAYING

Amicus Therapeutics CEO John Crowley

0:00 30:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talks at GS?

This episode is 30 minutes long.

When was this Talks at GS episode published?

This episode was published on June 4, 2021.

Can I download this Talks at GS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!